Clinical Trial Update: Cognitive Neuroscience of Autism Spectrum Disorders

View source ↗

Summary

The NIMH-sponsored cognitive neuroscience study on autism spectrum disorders has completed enrollment and the trial status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asperger Syndrome
• Autism Spectrum Disorder
• Intellectual Disability

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Asperger's Disorder, Mental Retardation | Status: COMPLETED